Product Images Atorvastatin Calcium

This is a partial output from a study or clinical trial with Atorvastatin, a commonly prescribed cholesterol-lowering medication. It includes a graph displaying the Cumulative Hazard (%) over four years of treatment and a statistically significant hazard ratio (0.53) in comparison to a placebo. The output is incomplete and lacks any further details.*

The text shows the results of a study comparing the effectiveness of two different drugs, Horvastatin at 10mg and Sorvastatin at 80mg, on reducing the occurrence of a major cardiovascular endpoint. The study results indicate that the Horvastatin drug had a 0.78 hazard ratio with a P-value of 0.0002, implying that it was significantly more effective in reducing the incidence of the endpoint in question compared to Sorvastatin. However, the text is not clear about what the endpoint was or what the percentage figures in the table mean.*

This is a description of a medication called Atorvastatin Calcium. The medication is available in tablet form with a dosage of 10mg atorvastatin. The tablet contains Atorvastatin Calcium equivalent. The package comes with 30 Pills, and the pharmacy should dispense the patient information leaflet separately to each patient. The package is child-resistant, and there are instructions on how to unlock it. The medication is manufactured by Apotex Inc. and distributed by Cambridge Therapeutic Technologies, LLC, Teaneck, New Jersey.*

This is a pharmaceutical package insert for Atorvastatin Calcium Tablets. The tablets come in a quantity of 30 and have a usual dosage of 20 mg. The medication should be dispensed in a light-resistant container and kept out of reach of children. The packaging is child-resistant with instructions included. The text contains important warnings about not using the product if the package is damaged, instructions for storage, prescribing information, manufacturing and distribution information, and disclaimers.*

This appears to be a package insert for Atorvastatin Calcium Apotex 40mg, a cardiovascular medication. It contains warnings to keep the drugs out of the reach of children and to not use it if the package is broken. It also provides instructions on how to use the child-resistant packaging and how to manage daily dosing schedules. The package should be stored between 20°C to 25°C. The insert is manufactured by Almora RX and distributed by Cambridge Therapeutic Technologies, LLC. Proofreading is requested before signing off on packaging approval.*